A citation-based method for searching scientific literature

Alessio Basolo, Antonio Matrone, Rossella Elisei, Ferruccio Santini. Semin Cancer Biol 2022
Times Cited: 8







List of co-cited articles
57 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.
Robert C Doebele, Alexander Drilon, Luis Paz-Ares, Salvatore Siena, Alice T Shaw, Anna F Farago, Collin M Blakely, Takashi Seto, Byung Chul Cho, Diego Tosi,[...]. Lancet Oncol 2020
449
62


Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
Lori J Wirth, Eric Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang, Jochen Lorch, Francis Worden, Marcia Brose, Jyoti Patel, Sophie Leboulleux,[...]. N Engl J Med 2020
171
50

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.
Vivek Subbiah, Robert J Kreitman, Zev A Wainberg, Jae Yong Cho, Jan H M Schellens, Jean Charles Soria, Patrick Y Wen, Christoph Zielinski, Maria E Cabanillas, Gladys Urbanowitz,[...]. J Clin Oncol 2018
353
37

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, Steven G DuBois, Ulrik N Lassen, George D Demetri, Michael Nathenson, Robert C Doebele, Anna F Farago, Alberto S Pappo,[...]. N Engl J Med 2018
37

Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.
Seong-Keun Yoo, Seungbok Lee, Su-Jin Kim, Hyeon-Gun Jee, Byoung-Ae Kim, Hyesun Cho, Young Shin Song, Sun Wook Cho, Jae-Kyung Won, Jong-Yeon Shin,[...]. PLoS Genet 2016
176
37

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A Knauf, Ronak H Shah, Snjezana Dogan, Julio C Ricarte-Filho, Gnana P Krishnamoorthy, Bin Xu,[...]. J Clin Invest 2016
543
37

Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.
Nikita Pozdeyev, Laurie M Gay, Ethan S Sokol, Ryan Hartmaier, Kelsi E Deaver, Stephanie Davis, Jena D French, Pierre Vanden Borre, Daniel V LaBarbera, Aik-Choon Tan,[...]. Clin Cancer Res 2018
202
37

Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes.
Ian Ganly, Vladimir Makarov, Shyamprasad Deraje, YiYu Dong, Ed Reznik, Venkatraman Seshan, Gouri Nanjangud, Stephanie Eng, Promita Bose, Fengshen Kuo,[...]. Cancer Cell 2018
106
37

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
37

Cabozantinib in progressive medullary thyroid cancer.
Rossella Elisei, Martin J Schlumberger, Stefan P Müller, Patrick Schöffski, Marcia S Brose, Manisha H Shah, Lisa Licitra, Barbara Jarzab, Viktor Medvedev, Michael C Kreissl,[...]. J Clin Oncol 2013
658
37

A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.
Cristina Romei, Raffaele Ciampi, Rossella Elisei. Nat Rev Endocrinol 2016
162
37

Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study.
Vivek Subbiah, Mimi I Hu, Lori J Wirth, Martin Schuler, Aaron S Mansfield, Giuseppe Curigliano, Marcia S Brose, Viola W Zhu, Sophie Leboulleux, Daniel W Bowles,[...]. Lancet Diabetes Endocrinol 2021
49
37

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli,[...]. J Clin Oncol 2012
849
37

Precision Targeted Therapy with BLU-667 for RET-Driven Cancers.
Vivek Subbiah, Justin F Gainor, Rami Rahal, Jason D Brubaker, Joseph L Kim, Michelle Maynard, Wei Hu, Qiongfang Cao, Michael P Sheets, Douglas Wilson,[...]. Cancer Discov 2018
195
37

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
929
37

Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing.
Raffaele Ciampi, Cristina Romei, Teresa Ramone, Alessandro Prete, Alessia Tacito, Virginia Cappagli, Valeria Bottici, David Viola, Liborio Torregrossa, Clara Ugolini,[...]. iScience 2019
49
37

Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations.
V Subbiah, T Shen, S S Terzyan, X Liu, X Hu, K P Patel, M Hu, M Cabanillas, A Behrang, F Meric-Bernstam,[...]. Ann Oncol 2021
52
37

Comparative efficacy and safety of tyrosine kinase inhibitors for thyroid cancer: a systematic review and meta-analysis.
Takaaki Oba, Tatsunori Chino, Ai Soma, Tadafumi Shimizu, Mayu Ono, Tokiko Ito, Toshiharu Kanai, Kazuma Maeno, Ken-Ichi Ito. Endocr J 2020
6
33

Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing.
Huanli Duan, Yan Li, Peizhen Hu, Jie Gao, Jianming Ying, Wanni Xu, Danhui Zhao, Zhe Wang, Junyi Ye, Analyn Lizaso,[...]. Histopathology 2019
29
25

Progresses Toward Precision Medicine in RET-altered Solid Tumors.
Carmen Belli, Santosh Anand, Justin F Gainor, Frederique Penault-Llorca, Vivek Subbiah, Alexander Drilon, Fabrice Andrè, Giuseppe Curigliano. Clin Cancer Res 2020
12
25


Follicular cell-derived thyroid cancer.
Henning Dralle, Andreas Machens, Johanna Basa, Vahab Fatourechi, Silvia Franceschi, Ian D Hay, Yuri E Nikiforov, Furio Pacini, Janice L Pasieka, Steven I Sherman. Nat Rev Dis Primers 2015
50
25

TERT promoter mutations in thyroid cancer.
Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2016
191
25


Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.
Raj K Gopal, Kirsten Kübler, Sarah E Calvo, Paz Polak, Dimitri Livitz, Daniel Rosebrock, Peter M Sadow, Braidie Campbell, Samuel E Donovan, Salma Amin,[...]. Cancer Cell 2018
100
25


A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer.
Martin Schlumberger, Barbara Jarzab, Maria E Cabanillas, Bruce Robinson, Furio Pacini, Douglas W Ball, Judith McCaffrey, Kate Newbold, Roger Allison, Renato G Martins,[...]. Clin Cancer Res 2016
134
25

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
25

State-of-the-Art Strategies for Targeting RET-Dependent Cancers.
Vivek Subbiah, Dong Yang, Vamsidhar Velcheti, Alexander Drilon, Funda Meric-Bernstam. J Clin Oncol 2020
76
25

Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice.
Elena Tirrò, Federica Martorana, Chiara Romano, Silvia Rita Vitale, Gianmarco Motta, Sandra Di Gregorio, Michele Massimino, Maria Stella Pennisi, Stefania Stella, Adriana Puma,[...]. Genes (Basel) 2019
47
25

Neoadjuvant selpercatinib for advanced medullary thyroid cancer.
Yelda Jozaghi, Mark Zafereo, Michelle D Williams, Maria K Gule-Monroe, Jennifer Wang, Elizabeth G Grubbs, Ara Vaporciyan, Mimi I Hu, Naifa Busaidy, Ramona Dadu,[...]. Head Neck 2021
17
25

Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial.
Dapeng Li, Yihebali Chi, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng,[...]. Clin Cancer Res 2021
12
25

Management of treatment-related toxicities in advanced medullary thyroid cancer.
Marcia S Brose, Keith C Bible, Laura Q M Chow, Jill Gilbert, Carolyn Grande, Francis Worden, Robert Haddad. Cancer Treat Rev 2018
26
25

Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response.
Laura Valerio, Valeria Bottici, Antonio Matrone, Paolo Piaggi, David Viola, Virginia Cappagli, Laura Agate, Eleonora Molinaro, Raffaele Ciampi, Alessia Tacito,[...]. Endocr Relat Cancer 2020
9
25

Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.
Carrie C Lubitz, Peter M Sadow, Gilbert H Daniels, Lori J Wirth. Thyroid 2021
5
40

Precision therapy for RET-altered cancers with RET inhibitors.
Kyaw Z Thein, Vamsidhar Velcheti, Blaine H M Mooers, Jie Wu, Vivek Subbiah. Trends Cancer 2021
10
25

Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer.
Viktoria F Koehler, Pia Adam, Karin Frank-Raue, Friedhelm Raue, Elke Berg, Eva Hoster, Stephanie Allelein, Matthias Schott, Matthias Kroiss, Christine Spitzweg. Thyroid 2021
17
25

2012 European thyroid association guidelines for metastatic medullary thyroid cancer.
M Schlumberger, L Bastholt, H Dralle, B Jarzab, F Pacini, J W A Smit. Eur Thyroid J 2012
83
25

Survival and death causes in differentiated thyroid carcinoma.
Carmen F A Eustatia-Rutten, Eleonora P M Corssmit, Nienke R Biermasz, Alberto M Pereira, Johannes A Romijn, Johannes W Smit. J Clin Endocrinol Metab 2006
194
25

Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer.
A Matrone, A Prete, A Nervo, A Ragni, L Agate, E Molinaro, C Giani, L Valerio, E Minaldi, A Piovesan,[...]. J Endocrinol Invest 2021
4
50

Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients.
C Resteghini, S Cavalieri, D Galbiati, R Granata, S Alfieri, C Bergamini, P Bossi, L Licitra, L D Locati. Best Pract Res Clin Endocrinol Metab 2017
46
25

Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities.
Loredana Lorusso, Virginia Cappagli, Laura Valerio, Carlotta Giani, David Viola, Luciana Puleo, Carla Gambale, Elisa Minaldi, Maria Cristina Campopiano, Antonio Matrone,[...]. Int J Mol Sci 2021
12
25

Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer.
Tanner Fullmer, Maria E Cabanillas, Mark Zafereo. Front Endocrinol (Lausanne) 2021
7
28

Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives.
Lucieli Ceolin, Marta Amaro da Silveira Duval, Antônio Felippe Benini, Carla Vaz Ferreira, Ana Luiza Maia. Endocr Relat Cancer 2019
40
25

NTRK Fusions, from the Diagnostic Algorithm to Innovative Treatment in the Era of Precision Medicine.
Federica Zito Marino, Francesca Pagliuca, Andrea Ronchi, Immacolata Cozzolino, Marco Montella, Massimiliano Berretta, Maria Elena Errico, Vittoria Donofrio, Roberto Bianco, Renato Franco. Int J Mol Sci 2020
25
25

Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial.
Michael C Kreissl, Lars Bastholt, Rossella Elisei, Robert Haddad, Ole Hauch, Barbara Jarząb, Bruce Robinson, Raffaella Colzani, Meredith Foster, Richard Weiss,[...]. J Clin Oncol 2020
15
25

Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience.
Assaf Moore, Yael Bar, Corinne Maurice-Dror, Inbar Finkel, Hadar Goldvaser, Elizabeth Dudnik, Daniel A Goldstein, Noa Gordon, Salem Billan, Orit Gutfeld,[...]. Medicine (Baltimore) 2021
3
66

2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.
Keith C Bible, Electron Kebebew, James Brierley, Juan P Brito, Maria E Cabanillas, Thomas J Clark, Antonio Di Cristofano, Robert Foote, Thomas Giordano, Jan Kasperbauer,[...]. Thyroid 2021
63
25

Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma.
Antonio Matrone, Carla Gambale, Alessandro Prete, Paolo Piaggi, Virginia Cappagli, Valeria Bottici, Cristina Romei, Raffaele Ciampi, Liborio Torregrossa, Luigi De Napoli,[...]. Cancers (Basel) 2020
6
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.